Regulatory Writing Clinical Project Management Strategic Communications
|
|
|
- Augustine French
- 10 years ago
- Views:
Transcription
1 Regulatory Writing Clinical Project Management Strategic Communications
2 FLEXIBLE. STRATEGIC. INFORMED. COMPLIANT. For over 15 years, Niche Science and Technology has been providing outstanding medical writing and project management services to some of the biggest names in the business. Our clients regularly turn to us to overcome gaps in their resources and knowledge and they know they can rely on us to get the job done. The highly experienced Niche team consists of specialists in regulatory writing, scientific communications and clinical project management. Over the years we have built up relationships with many different clients, providing pivotal writing and project management support for hundreds of clinical studies, regulatory documents and manuscripts. Our clients request our services time and time again, and recommend us to others in turn. Most importantly, every member of the Niche team is driven by an enthusiasm for the brief, a passion for quality, and the satisfaction of providing the personal touch to everything we deliver. KNOWLEDGEABLE AND PROFESSIONAL IN APPROACH, EXECUTING NEW WORK IN A SKILLED MANNER GlaxoSmithKline
3 HOW CAN WE HELP? Regulatory documents and submissions Clinical study protocols and reports Clinical project management Standard operating procedures Primary manuscripts Data management and statistical analysis Training packages Conference materials, posters, abstracts and slide sets Reviews, monographs and brochures REGULATORY DOCUMENTS AND SUBMISSIONS On-time delivery and submission of your regulatory documents helps achieve your development targets and shortens time to market. We provide medical writing, editing and project co-ordination services for CTAs (Clinical Trial Applications), IBs (Investigator Brochures), IMPDs (Investigational Medicinal Product Dossiers) and CTD (Common Technical Document) submissions and all other regulatory documentation. Our knowledge of the changing regulatory environment and extensive experience of co-ordinating submissions means we can offer a total service tailored to your requirements. CLINICAL STUDY PROTOCOLS AND REPORTS These are the foundation documents of your development programme. Integrating with your team, we can produce high quality clinical study protocols and reports using either your preferred templates or our own ICH compliant templates. Our experience extends across a wide range of therapeutic areas including oncology, respiratory, diabetes and infectious diseases. We have extensive experience of writing study reports; over the last decade we have written over 500 CSRs (Clinical Study Reports) for one Blue Chip Pharmaceutical company alone. CLINICAL PROJECT MANAGEMENT Integral to the successful delivery of any clinical study, we can support you in the management of specific aspects of a study through to managing the entire development programme. Our team have experience across all phases of development and we have run studies using biologicals as well as new chemical entities. Services that can be contracted individually or as a package include study design, site selection, document development, ethics submissions, organisation of Investigator meetings, clinical governance of ongoing studies, management of the TMF (Trial Master File), vendor management, budget control, risk management and contingency planning.
4 STANDARD OPERATING PROCEDURES (SOPs) Standard operating procedures are required both by GCP (Good Clinical Practice) and local regulations and will form a key part of any audit review. We can help you develop either a single SOP or an entire set of documents according to your needs while ensuring that they also meet prescribed requirements. We have developed entire quality management systems for several companies. In addition, we can develop document templates drawing on our knowledge of ICH and GCP recommendations, local requirements and our extensive experience in writing these documents. PRIMARY MANUSCRIPTS Now an essential tool in demonstrating the transparency of the pharmaceutical industry, primary manuscripts also provide a major contribution to the successful launch of a product. Published materials provide the reference source for monographs, advertising, sales force documents and other promotional materials before and after launch. We can write and submit manuscripts for publication in peer-reviewed journals. Our experience also allows us to optimise the communication of key messages through publication planning, targeting your audience through journal selection. DATA MANAGEMENT AND STATISTICAL ANALYSIS Data management and statistical analysis planning are essential to ensure that the study produces reliable, robust results which are powered to meet the study endpoints. Our services support the acquisition, analysis and presentation of data. Either directly or in conjunction with our strategic partners we can perform sample size calculations; write or review statistical analysis plans and the statistical section of the protocol; generate randomisation schedules; and design and validate source documents, CRFs (paper or electronic) and databases. We can also review and enter data; undertake statistical programming; and generate compliant and report-ready tables, listings and figures. TIMELY ADVICE, EXCELLENT QUALITY DOCUMENTATION AND RESPONSIVE TO OUR NEEDS. Funxional Therapeutics
5 TRAINING PACKAGES Training packages form a core resource for any company. Robust new media materials communicate messages and information in an engaging way, enhancing the learning experience. We can create innovative training programmes for the effective education of your target audience: customers, representatives, scientists or patients. Our distance learning materials are varied and easy to use, providing a cost-effective and convenient way to train and brief your team members. CONFERENCE MATERIALS, POSTERS, ABSTRACTS AND SLIDE SETS We can help you raise awareness, maintain market interest, and communicate important data to key audiences, long before publication in peer-reviewed journals. Carefully written delegate materials ensure that attendees retain your conference materials and take your key findings away from symposia. We can provide well-written materials for a variety of media and have covered many congresses and symposia. REVIEWS, MONOGRAPHS AND BROCHURES Stimulating product interest and debate before launch or during a product s lifetime is key. These documents often have shorter lead times to publication and provide an opportunity to reach defined target groups. Our scientists combine their experience with client requirements to select the appropriate data for reviews, monographs and brochures. Through these publications we are able to convey your key messages to your chosen audiences. Niche Science & Technology Unit 26 Falstaff House Bardolph Road Richmond TW9 2LH T: +44 (0) E: [email protected] W:
A clinical research organization
A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced
REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN CLINICAL RESEARCH METHODOLOGY (PDipClinResMethodology)
452 REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN CLINICAL RESEARCH METHODOLOGY (PDipClinResMethodology) (See also General Regulations) M.57 Admission requirements To be eligible for admission to the courses
Oversight of Clinical Trials in Europe - Member State perspective. Gunnar Danielsson Senior Expert Pharmaceutical Inspector
Oversight of Clinical Trials in Europe - Member State perspective Gunnar Danielsson Senior Expert Pharmaceutical Inspector Oversight of Clinical Trials Oversight of clinical trials occur on many different
Data-management and Biostatistics
Data-management and Biostatistics OnQ Data prides itself in being able to offer a cost-effective flexible service that result in the hassle-free generation of clean, high quality scientific data in the
What We Are..! www.ardent-cro.com
Your Trusted CRO! Regus, Level-2, Connaught Place, Bund Garden Road, Pune-411001, MH, India. Phone: 020-65-31-31-71 Email: [email protected] Web: What We Are..! Ardent Clinical Research Services is
Needs, Providing Solutions
Identifying Needs, Providing Solutions 1 I n d u s t r y The growth of medical research and the countless innovations coming from the pharmaceutical, biotechnology and medical device industry, has improved
The agency perspective
The agency perspective 16 January 2014 Anna Palmer Scientific Services Manager Contents What is medical communications? How did I get here? Medical communications vs other agencies What do we actually
Infoset builds software and services to advantage business operations and improve patient s life
Infoset builds software and services to advantage business operations and improve patient s life Clinical Data Management ecrf & EDC Patient Support Programs Medication Adherence Mobile e-health Big Data
Even we will get to use your product someday. Enough reason for us to deliver.
Even we will get to use your product someday. Enough reason for us to deliver. ClinInvent: Putting our heart and soul behind the research. At ClinInvent, when we talk about clinical research it s not just
The agency perspective: What we do and how we do it
The agency perspective: What we do and how we do it Tim Ryder and Olga Dai 15 July 2011 Who are we? Tim Ryder Scientific Team Leader, Darwin HC MA in Biochemistry; DPhil in Physiology 10 years of experience
Overview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience
ICH and Singapore Dr Christina Lim Deputy Group Director, Health Product Regulation Group Senior Advisor, International Collaboration Health Sciences Authority Singapore November 2008 Overview Health Science
Clinical Research in Mauritius
BOARD OF INVESTMENT Clinical Research in Mauritius This document provides an informative summary of the procedure to apply for a clinical research protocol in Mauritius. Contents INTRODUCTION... 2 I. APPLICATION
Careers in Medical and Scientific Writing
Careers in Medical and Scientific Writing Laura McCormick, PhD Vice President Associate Practice Leader Tamara Fink, PhD Associate Scientific Director ProEd Communications, Inc Beachwood, Ohio Agenda Introduction
The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
New Investigator Collaborations and Interactions: Regulatory
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité New Investigator Collaborations and Interactions: Regulatory NCIC Clinical Trials Group New Investigator Clinical Trials
CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator
Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley
TRIAL MASTER FILE- SPONSORED
gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER
Job Profile Clinical Research Associate III (CRA)
PART 1 - PROFILE You are an experienced CRA with a strong background in Clinical Research who is passionate about drug development and are seeking a challenging and rewarding career in a quality focussed
Global regulatory affairs role in the biopharmaceutical industry
CHAPTER TWO Global affairs role in the biopharmaceutical industry 2.1 Overview 2.2 Global affairs organization 2.3 Role of global affairs 2.4 Key functions and activities 2.5 Global strategy 2.6 Global
The Clinical Trials Regulation EU No 536/2014: and Phase I trials
The Clinical Trials Regulation EU No 536/2014: and Phase I trials EUFEMED, Brussels, 20 May 2015 Presented by Fergus Sweeney Head, Inspections and Human Medicines Pharmacovigilance An agency of the European
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS
ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:
How GSK supports independent medical education
How GSK supports independent medical education GlaxoSmithKline s mission is to help people do more, feel better and live longer. As part of this mission we are embarking on a new initiative in how we support
A responsible approach to clinical trials. Bioethics in action
A responsible approach to clinical trials Bioethics in action What is bioethics? At Novo Nordisk bioethics is the expression used for all ethical issues related to the use of life science technologies
gsop-32-02 - Vendor Assessment SOP page 1 of 10
gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development
Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services
Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services Providing a wide range of clinical research services Abt Associates Clinical Trials (AACT) is dedicated to providing
Archiving of Research Documentation
Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment
Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL
Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE
BUILDING QUALITY INTO CLINICAL TRIALS AN FDA PERSPECTIVE Jean Toth-Allen, Ph.D. Biophysicist Office of Good Clinical Practice Office of the Commissioner May 14, 2012 1 Overview I. Background why we are
EMA Update Clinical Trials
EMA Update Clinical Trials Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency 16 October 2012 An agency of the European Union Disclaimer The views presented in this presentation/these
Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey
Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity
Clinical Trial Oversight: Ensuring GCP Compliance, Patient Safety and Data Integrity Michelle Quaye Regulatory Manager, Advanced Therapy Trials University College London Overview The Principles of Good
EUROPEAN INDUSTRIAL PHARMACISTS GROUP
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guide to Good Regulatory Practice Acknowledgments: Valérie LACAMOIRE, Conseil Central de la section B de l Ordre des Pharmaciens Kelsey MOWER, Industrial Pharmacists
Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research Samples
Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research Samples UKCRC Registered CTUs Network Guidance for CTUs on Assessing the Suitability of Laboratories Processing Research
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager
Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name
MAKE THE SWITCH TO ELECTRONIC DATA CAPTURE
MAKE THE SWITCH TO ELECTRONIC DATA CAPTURE Sophie McCallum, Director of Operations, Clinovo INTRODUCTION Electronic Data Capture (EDC) collects clinical trial data electronically rather than on paper.
Sheffield Kidney Institute. Planning a Clinical Trial
Planning a Clinical Trial Clinical Trials Testing a new drug Ethical Issues Liability and Indemnity Trial Design Trial Protocol Statistical analysis Clinical Trials Phase I: Phase II: Phase III: Phase
Signature Requirements for the etmf
Wingspan Technology Signature Requirements for the etmf A Regulatory and Technological Assessment Kathie Clark Director, Product Management Wingspan Technology 1 November 2012 Signature Requirements for
The New EU Clinical Trials Regulation: The Good, the Bad, the Ugly
A Full-Service International CRO The New EU Clinical Trials Regulation: The Good, the Bad, the Ugly Dr. Martine Dehlinger-Kremer Vice President, Global Medical and Regulatory Affairs The original intent
The Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
EU Clinical Trials Regulation Regulation EU 536/2014
EU Clinical Trials Regulation Regulation EU 536/2014 María Jesús Zafra Director, QA & Compliance Table of contents 1 2 3 4 Introduction Timelines and main changes Highlights 5 Impact on company processes
Global Policy on Interactions with Healthcare Professionals
Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Pfizer is committed to collaborating with physicians and other healthcare professionals,
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
Clinical Data Management Overview
The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART
EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,
Presented by Rosemarie Bell 24 April 2014
Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April
Operational aspects of a clinical trial
Operational aspects of a clinical trial Carlo Tomino Pharm.D. Coordinator Pre-authorization Department Head of Research and Clinical Trial Italian Medicines Agency Mwanza (Tanzania), June 11, 2012 1 Declaration
The Study Site Master File and Essential Documents
The Study Site Master File and Essential Documents Standard Operating Procedure Office of Health and Medical Research Queensland Health SOP reference: 002 Version number: 1 Effective date: 01 June 2010
Pharmaceutical Companies and Medical Publishers Working together in a world of increasing regulation
Pharmaceutical Companies and Medical Publishers Working together in a world of increasing regulation Sarah L Feeny Head of Scientific Direction, Complete Medical Communications Board of Trustees, International
PG Certificate / PG Diploma / MSc in Clinical Pharmacy
PG Certificate / PG Diploma / MSc in Clinical Pharmacy Programme Information September 2014 Entry School of Pharmacy Queen s University Belfast Queen s University Belfast - Clinical Pharmacy programme
We set things in motion and keep them moving. Metronomia Clinical Research Services
We set things in motion and keep them moving Metronomia Clinical Research Services Our customers love the fact that we keep up with their individual tempos. Dorothea Wessiepe, Director Biostatistics Metronomia:
REGULATIONS FOR THE POSTGRADUATE CERTIFICATE IN PUBLIC HEALTH (PCPH) (Subject to approval)
512 REGULATIONS FOR THE POSTGRADUATE CERTIFICATE IN PUBLIC HEALTH (PCPH) (Subject to approval) (See also General Regulations) M.113 Admission requirements To be eligible for admission to the programme
Job Description. Professionally accountable to the Medical Director with respect to Trust-wide Medicines Optimisation.
Job Description JOB DETAILS Job Title: Chief of Pharmacy Band: 9 Hours: 37.5 Department / Ward: Directorate: Pharmacy Cross Site Central Clinical Services ORGANISATIONAL ARRANGEMENTS Operationally accountable
2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials
L1 2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager,
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
de formation continue Diploma of Advanced Studies Management of Clinical Trials Good Clinical Practice Implementation and Quality Processes
DAS Diplôme de formation continue Diploma of Advanced Studies Management of Clinical Trials Good Clinical Practice Implementation and Quality Processes October 2015 September 2016 CRC Centre de Recherche
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009
Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency
Clinical Trials Facilitation Groups
Clinical Trials Facilitation Groups Guidance document for a Voluntary Harmonisation Procedure (VHP) for the assessment of multinational Clinical Trial Applications Version 2 Table of contents Doc. Ref.:
White Paper The EU Clinical Trials Regulation Main Changes and Challenges
White Paper The EU Clinical Trials Regulation Main Changes and Challenges Table of Contents 1. Introduction... 3 2. Main Changes and Associated Challenges... 4 2.1 Procedure for Initial Authorisation...
Consultation: Two proposals for registered nurse prescribing
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
NORWICH CLINICAL TRIALS UNIT OVERVIEW
NORWICH CLINICAL TRIALS UNIT OVERVIEW This document provides an overview of the Norwich Clinical Trials Unit. Sections 1 to 3 describe the Norwich Clinical Trials Unit remit and structure. Section 4 gives
R&D Administration Manager. Research and Development. Research and Development
Document Title: Document Number: Patient Recruitment SOP031 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D Administration Manager,
Essential Documents for Clinical Trial Research. Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office
Essential Documents for Clinical Trial Research Erin Cherban, MSc., CCRP Centre for Health Evaluation and Outcome Sciences Manager, Clinical Research Development Office Document Examples See the following
1.2 - Overview of Regulation of Clinical Trials in Canada
1.2 - Overview of Regulation of Clinical Trials in Canada Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager, Clinical Group I Office
STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders
STANDARD OPERATING PROCEDURE FOR RESEARCH Management of Essential Documents and Trial Folders Author Linda Ward Author s Job Title QA Coordinator Division Department Version number 2 Ref SOP/CLN/001/2
Importing pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: SOP number: SOP category: Document Control GE-003 General SOP history Version number: 01 Version date: 1 March 2013 Effective
The Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research
The Importance of Good Clinical Data Management and Statistical Programming Practices to Reproducible Research Eileen C King, PhD Research Associate Professor, Biostatistics Acting Director, Data Management
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
Clinical research: where are we with the new (Paediatric) RC trial Regulation
where are we with the new (Paediatric) RC trial Regulation, MD, PhD Ethical Committee DEEP Former member of the PDCO EMA With the aid of Fabio D'Atri European commission and Anabela Marcal of EMA The new
The Monitoring Visit. Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis
The Monitoring Visit Denise Owensby, CCRP Sr. Clinical Research Coordinator Clinical & Translational Science Center University of California, Davis Disclosure The information herein is not intended to
RAPS ONLINE UNIVERSITY
RAPS ONLINE UNIVERSITY Practical education and training for business success. For regulatory professionals, there is only one name to know and trust for online education and training RAPS Online University.
Annex 7 Guidelines for the preparation of a contract research organization master file
World Health Organization WHO Technical Report Series, No. 957, 2010 Annex 7 Guidelines for the preparation of a contract research organization master file Background 1. General information 2. Quality
Medical Writing. What is medical writing? What qualifications and skills do I need?
European Medical Writers Association Medical Writing Ever thought about medical writing as a career? If you want to get away from scientific research, but still use your scientific knowledge and skills,
Summary of the role and operation of NHS Research Management Offices in England
Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices
Speed to Market Abbott Nutrition Experience in Streamlining the Pediatric Clinical Research Process
Speed to Market Abbott Nutrition Experience in Streamlining the Pediatric Clinical Research Process Geraldine Baggs, Suzanne Monnin, Deborah Shye, Sue Zhang Abbott Nutrition Research & Development Abbott
Bringing knowledge to life
Bringing knowledge to life High-impact content, flexible delivery informahealthcare.com Committed to Quality Content At Informa Healthcare, our mission is to connect scientists, researchers, and clinicians
The Role of Regional Medical Advisor (RMA)-Field Medical. Dr. Aju Abraham Varghese Pfizer India. Feb 22 nd 2014
The Role of Regional Medical Advisor (RMA)-Field Medical Dr. Aju Abraham Varghese Pfizer India Feb 22 nd 2014 Disclaimer The opinions expressed in this presentation are solely those of the presenter and
Trial Delivery SOP 05 Trial Archiving
Gloucestershire Research and Development Consortium Standard Operating Procedure R&D SOP TD 05Trial Archiving Trial Delivery SOP 05 Trial Archiving IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO
Clinical Trials and Safety Surveillance of Drugs in Development
Clinical Trials and Safety Surveillance of Drugs in Development Hoda Eid, M.Sc., Ph.D. Manager, ADR Unit Office of Clinical Trials Therapeutic Products Directorate [email protected] Overview Clinical
Role Description Service Catalogue Specialist
Role Description Service Catalogue Specialist Cluster Agency Division/Branch/Unit Location Transport Transport for NSW People and Corporate Services/Group Information Technology Sydney Classification/Grade/Band
MedDRA in clinical trials industry perspective
MedDRA in clinical trials industry SFDA ICH MedDRA Workshop, Beijing, 13 14 May 2011 Christina Winter, MD, FFPM Medical director GlaxoSmithKline R&D / ICH MedDRA Management Board 2011 ICH International
What is necessary to provide good clinical data for a clinical trial?
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
Quality Management in Clinical Trials
CLINICAL CASE STUDY SERIES Quality Management in Clinical Trials Clinical trials are conducted to collect the data necessary to provide information for academia, industry, and regulators to make decisions
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health
Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health We are responsible for acquiring, analyzing, and protecting medical information vital to providing quality patient care HIM professionals ensure
